/Companies

Evercrisp

New York, US · Founded 2021 · 1 known investors

Find your way into Evercrisp

Sign up to see every warm intro you have to Evercrisp

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Evercrisp team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Evercrisp develops machine learning-engineered miniproteins that enable targeted delivery of genetic medicine payloads to previously inaccessible tissues without relying on viral vectors or nanoparticles. The company serves patients with limited treatment options across diverse genetic diseases by making genome editing and oligonucleotide therapies safer and more effective.

Founders & leadership

Evercrisp was founded in 2021 by Tanja Kortemme.

TKTanja Kortemme
Tanja KortemmeFounder
JD
Jennifer Doudna, Ph.D.
TK
Tanja Kortemme, Ph.D.
SL
Spiros Liras, Ph.D.

Board

ABAnna Batarina
Anna BatarinaBoard directorPartner at Apple Tree Venture Management Llc
SH
Seth HarrisonBoard directorFounder and Managing Partner at Apple Tree Venture Management Llc
SLSpiros Liras
Spiros LirasBoard directorVenture Partner at Apple Tree Venture Management Llc

Investors · 1

ATPreportedAustin

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$3.5M disclosed across 1 round · 2021

▶$3.5MraisedAug 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Anna BatarinaDirector
  • Seth HarrisonDirector
  • Spiros LirasExecutive Officer, Director
  • Tanja KortemmeDirector
Offering amount
$75M
Amount sold
$3.5M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Evercrisp do?
Evercrisp develops machine learning-engineered miniproteins that enable targeted delivery of genetic medicine payloads to previously inaccessible tissues without relying on viral vectors or nanoparticles. The company serves patients with limited treatment options across diverse genetic diseases by making genome editing and oligonucleotide therapies safer and more effective.
Who founded Evercrisp?
Evercrisp was founded by Tanja Kortemme in 2021.
Who are Evercrisp's investors?
Evercrisp's investors include ATP.
How much funding has Evercrisp raised?
Evercrisp has disclosed $3.5M raised across 1 round.
Where is Evercrisp headquartered?
Evercrisp is headquartered in New York, US.